PL2084172T3 - Nowe pochodne 1,1-ditlenku 1,4-benzotiepiny podstawione resztami benzylowymi, sposób ich wytwarzania, środki lecznicze zawierające te związki i ich zastosowanie - Google Patents

Nowe pochodne 1,1-ditlenku 1,4-benzotiepiny podstawione resztami benzylowymi, sposób ich wytwarzania, środki lecznicze zawierające te związki i ich zastosowanie

Info

Publication number: PL2084172T3
Authority: PL; Poland
Prior art keywords: benzothiepin; substituted; novel; compounds; benzyl groups
Prior art date: 2006-11-14

Application number

PL07819434T

Other languages

English (en)

Inventor

Wendelin Frick

Heiner Glombik

Stefan Theis

Hubert Heuer

Hans-Ludwig Schaefer

Werner Kramer

Original Assignee

Sanofi Aventis Deutschland

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-11-14

Filing date

2007-10-30

Publication date

2011-06-30

2007-10-30 Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland

2011-06-30 Publication of PL2084172T3 publication Critical patent/PL2084172T3/pl

Links

125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
239000003814 drug Substances 0.000 title 1
229940079593 drug Drugs 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
- C07H5/06—Aminosugars
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/02—Acyclic radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/02—Acyclic radicals
- C07H7/027—Keto-aldonic acids

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Hematology (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Saccharide Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

PL07819434T 2006-11-14 2007-10-30 Nowe pochodne 1,1-ditlenku 1,4-benzotiepiny podstawione resztami benzylowymi, sposób ich wytwarzania, środki lecznicze zawierające te związki i ich zastosowanie PL2084172T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE102006053635A DE102006053635B4 (de)	2006-11-14	2006-11-14	Neue mit Benzylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
EP07819434A EP2084172B1 (de)	2006-11-14	2007-10-30	Neue mit benzylresten substituierte 1,4-benzothiepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
PCT/EP2007/009393 WO2008058628A1 (de)	2006-11-14	2007-10-30	Neue mit benzylresten substituierte 1,4-benzothiepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung

Publications (1)

Publication Number	Publication Date
PL2084172T3 true PL2084172T3 (pl)	2011-06-30

Family

ID=39092812

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL07819434T PL2084172T3 (pl)	2006-11-14	2007-10-30	Nowe pochodne 1,1-ditlenku 1,4-benzotiepiny podstawione resztami benzylowymi, sposób ich wytwarzania, środki lecznicze zawierające te związki i ich zastosowanie

Country Status (37)

Country	Link
US (1)	US7956085B2 (pl)
EP (1)	EP2084172B1 (pl)
JP (1)	JP5301453B2 (pl)
KR (1)	KR101489168B1 (pl)
CN (1)	CN101535326B (pl)
AR (2)	AR063786A1 (pl)
AT (1)	ATE492554T1 (pl)
AU (1)	AU2007321496B2 (pl)
BR (1)	BRPI0718813B8 (pl)
CA (2)	CA2669230C (pl)
CL (1)	CL2007003262A1 (pl)
CO (1)	CO6190534A2 (pl)
CR (1)	CR10733A (pl)
CY (1)	CY1111166T1 (pl)
DE (2)	DE102006053635B4 (pl)
DK (1)	DK2084172T3 (pl)
EC (1)	ECSP099327A (pl)
ES (1)	ES2358371T3 (pl)
GT (1)	GT200900125A (pl)
HR (1)	HRP20110197T1 (pl)
IL (1)	IL198718A (pl)
MA (1)	MA30883B1 (pl)
MX (1)	MX2009003958A (pl)
MY (1)	MY148429A (pl)
NI (1)	NI200900076A (pl)
NO (2)	NO342236B1 (pl)
NZ (1)	NZ576762A (pl)
PE (1)	PE20081493A1 (pl)
PL (1)	PL2084172T3 (pl)
PT (1)	PT2084172E (pl)
RU (1)	RU2456282C2 (pl)
SI (1)	SI2084172T1 (pl)
SV (1)	SV2009003216A (pl)
TN (1)	TN2009000180A1 (pl)
TW (1)	TWI414530B (pl)
UY (1)	UY30709A1 (pl)
WO (1)	WO2008058628A1 (pl)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2025674A1 (de)	2007-08-15	2009-02-18	sanofi-aventis	Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DK2282991T3 (en) *	2008-05-02	2018-05-07	Sanofi Aventis Deutschland	METHOD OF PREPARING 1,4-BENZOTHIEPINE-1,1-DIOXIDE DERIVATIVES
EP2367554A4 (en)	2008-11-26	2020-03-25	Satiogen Pharmaceuticals, Inc.	Bile acid reflux inhibitor for the treatment of obesity and diabetes
EP4137137A1 (en) *	2010-05-26	2023-02-22	Satiogen Pharmaceuticals, Inc.	Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
EP2582709B1 (de)	2010-06-18	2018-01-24	Sanofi	Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
WO2012030165A2 (ko)	2010-08-31	2012-03-08	서울대학교산학협력단	P P A R δ 활성물질의 태자재프로그래밍용도
PL3400944T3 (pl)	2010-11-04	2020-11-16	Albireo Ab	Inhibitory ibat w leczeniu chorób wątroby
EP2567959B1 (en)	2011-09-12	2014-04-16	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
SG10201909122QA (en) *	2011-10-28	2019-11-28	Lumena Pharmaceuticals Inc	Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
US20140323412A1 (en) *	2011-10-28	2014-10-30	Lumena Pharmaceuticals, Inc.	Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
JO3301B1 (ar)	2013-04-26	2018-09-16	Albireo Ab	تعديلات بلورية على إيلوبيكسيبات
KR102560954B1 (ko)	2014-06-25	2023-07-31	이에이 파마 가부시키가이샤	고형 제제 및 그의 착색 방지 또는 착색 감소 방법
EP3012252A1 (en)	2014-10-24	2016-04-27	Ferring BV	Crystal modifications of elobixibat
CN108601745B (zh)	2016-02-09	2021-12-07	阿尔比里奥公司	口服考来烯胺制剂及其用途
US10441604B2 (en)	2016-02-09	2019-10-15	Albireo Ab	Cholestyramine pellets and methods for preparation thereof
US10786529B2 (en)	2016-02-09	2020-09-29	Albireo Ab	Oral cholestyramine formulation and use thereof
ES2874669T3 (es)	2016-02-09	2021-11-05	Albireo Ab	Formulación oral de colestiramina y uso de la misma
US10441605B2 (en)	2016-02-09	2019-10-15	Albireo Ab	Oral cholestyramine formulation and use thereof
CN111032019B (zh)	2017-08-09	2022-07-05	阿尔比里奥公司	考来烯胺颗粒、口服考来烯胺制剂及其用途
WO2019032027A1 (en)	2017-08-09	2019-02-14	Albireo Ab	CHOLESTYRAMINE TABLETS, ORAL FORMULATIONS OF CHOLESTYRAMINE AND THEIR USE
US10793534B2 (en)	2018-06-05	2020-10-06	Albireo Ab	Benzothia(di)azepine compounds and their use as bile acid modulators
EP3802504B1 (en)	2018-06-05	2023-01-18	Albireo AB	Benzothia(di)azepine compounds and their use as bile acid modulators
EP3810084A1 (en)	2018-06-20	2021-04-28	Albireo AB	Pharmaceutical formulation of odevixibat
US11801226B2 (en)	2018-06-20	2023-10-31	Albireo Ab	Pharmaceutical formulation of odevixibat
US10722457B2 (en)	2018-08-09	2020-07-28	Albireo Ab	Oral cholestyramine formulation and use thereof
US11549878B2 (en)	2018-08-09	2023-01-10	Albireo Ab	In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US11007142B2 (en)	2018-08-09	2021-05-18	Albireo Ab	Oral cholestyramine formulation and use thereof
TW202023625A (zh)	2018-08-23	2020-07-01	美商西雅圖遺傳學公司	抗tigit抗體
US10941127B2 (en)	2019-02-06	2021-03-09	Albireo Ab	Benzothiadiazepine compounds and their use as bile acid modulators
US10975045B2 (en)	2019-02-06	2021-04-13	Aibireo AB	Benzothiazepine compounds and their use as bile acid modulators
DK3921028T3 (da)	2019-02-06	2023-01-23	Albireo Ab	Benzothiadiazepinforbindelser og anvendelse deraf som galdesyremodulatorer
JP7562546B2 (ja)	2019-02-12	2024-10-07	ミルムファーマシューティカルズインコーポレイテッド	胆汁うっ滞性肝疾患を有する小児対象の成長を増加させる方法
DK4069360T3 (da)	2019-12-04	2024-02-26	Albireo Ab	Benzothia(di)azepinforbindelser og anvendelse deraf som galdesyremodulatorer
US11014898B1 (en)	2020-12-04	2021-05-25	Albireo Ab	Benzothiazepine compounds and their use as bile acid modulators
JP7696897B2 (ja)	2019-12-04	2025-06-23	アルビレオ・アクチボラグ	ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
ES2972045T3 (es)	2019-12-04	2024-06-10	Albireo Ab	Compuestos de benzotia(di)azepina y su uso como moduladores del ácido biliar
CN114761018B (zh)	2019-12-04	2025-12-02	阿尔比里奥公司	苯并硫杂二氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
CN116157389B (zh)	2020-08-03	2026-02-10	阿尔比里奥公司	苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
JP2023549226A (ja)	2020-11-12	2023-11-22	アルビレオエービー	進行性家族性肝内胆汁うっ滞症（ｐｆｉｃ）を処置するためのオデビキシバット
WO2022117778A1 (en)	2020-12-04	2022-06-09	Albireo Ab	Benzothia(di)azepine compounds and their use as bile acid modulators
TW202313579A (zh)	2021-06-03	2023-04-01	瑞典商艾爾比瑞歐公司	苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途
JP2025516153A (ja)	2022-04-22	2025-05-27	アルビレオ・アクチボラグ	Ａｓｂｔ阻害剤の皮下投与
AU2023285002A1 (en)	2022-06-09	2024-12-05	Albireo Ab	Treating hepatitis
US20240207286A1 (en)	2022-12-09	2024-06-27	Albireo Ab	Asbt inhibitors in the treatment of renal diseases
US20240382507A1 (en) *	2023-05-19	2024-11-21	Mirum Pharmaceuticals, Inc.	Pharmaceutical compositions comprising 2,3,4,5- tetrahydrobenzothiepin- 1,1-dioxide derivatives and the use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5994391A (en) *	1994-09-13	1999-11-30	G.D. Searle And Company	Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US6221897B1 (en) *	1998-06-10	2001-04-24	Aventis Pharma Deutschland Gmbh	Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
DE19825804C2 (de) *	1998-06-10	2000-08-24	Aventis Pharma Gmbh	1,4-Benzothiepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
CA2457976A1 (en) *	2001-08-22	2003-03-06	Aventis Pharma Deutschland Gmbh	Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
GB0121621D0 (en) *	2001-09-07	2001-10-31	Astrazeneca Ab	Chemical compounds
JP2005518347A (ja)	2001-11-02	2005-06-23	ジー．ディー．サールエルエルシー	頂端ナトリウム共依存性胆汁酸輸送（ａｓｂｔ）およびタウロコール酸塩取り込みの阻害剤としての新規一および二フッ化ベンゾチエピン化合物
GB0304194D0 (en)	2003-02-25	2003-03-26	Astrazeneca Ab	Chemical compounds
DE102005033099A1 (de)	2005-07-15	2007-01-18	Sanofi-Aventis Deutschland Gmbh	Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindung enthaltende Arzneimittel und dessen Verwendung

2006
- 2006-11-14 DE DE102006053635A patent/DE102006053635B4/de not_active Expired - Fee Related
2007
- 2007-10-30 MY MYPI20091688A patent/MY148429A/en unknown
- 2007-10-30 WO PCT/EP2007/009393 patent/WO2008058628A1/de not_active Ceased
- 2007-10-30 PL PL07819434T patent/PL2084172T3/pl unknown
- 2007-10-30 DE DE502007006055T patent/DE502007006055D1/de active Active
- 2007-10-30 ES ES07819434T patent/ES2358371T3/es active Active
- 2007-10-30 MX MX2009003958A patent/MX2009003958A/es active IP Right Grant
- 2007-10-30 NZ NZ576762A patent/NZ576762A/en unknown
- 2007-10-30 CN CN2007800424399A patent/CN101535326B/zh active Active
- 2007-10-30 AT AT07819434T patent/ATE492554T1/de active
- 2007-10-30 CA CA2669230A patent/CA2669230C/en active Active
- 2007-10-30 BR BRPI0718813A patent/BRPI0718813B8/pt active IP Right Grant
- 2007-10-30 RU RU2009122470/04A patent/RU2456282C2/ru active
- 2007-10-30 PT PT07819434T patent/PT2084172E/pt unknown
- 2007-10-30 KR KR1020097009914A patent/KR101489168B1/ko active Active
- 2007-10-30 EP EP07819434A patent/EP2084172B1/de active Active
- 2007-10-30 HR HR20110197T patent/HRP20110197T1/hr unknown
- 2007-10-30 AU AU2007321496A patent/AU2007321496B2/en active Active
- 2007-10-30 JP JP2009536625A patent/JP5301453B2/ja active Active
- 2007-10-30 NO NO20091893A patent/NO342236B1/no unknown
- 2007-10-30 CA CA2865332A patent/CA2865332C/en active Active
- 2007-10-30 DK DK07819434.7T patent/DK2084172T3/da active
- 2007-10-30 SI SI200730487T patent/SI2084172T1/sl unknown
- 2007-11-12 PE PE2007001553A patent/PE20081493A1/es not_active Application Discontinuation
- 2007-11-12 UY UY30709A patent/UY30709A1/es unknown
- 2007-11-12 TW TW096142599A patent/TWI414530B/zh active
- 2007-11-12 AR ARP070105027A patent/AR063786A1/es active IP Right Grant
- 2007-11-13 CL CL200703262A patent/CL2007003262A1/es unknown
2009
- 2009-04-03 SV SV2009003216A patent/SV2009003216A/es unknown
- 2009-04-20 CR CR10733A patent/CR10733A/es not_active Application Discontinuation
- 2009-05-04 NI NI200900076A patent/NI200900076A/es unknown
- 2009-05-06 CO CO09045559A patent/CO6190534A2/es not_active Application Discontinuation
- 2009-05-08 TN TNP2009000180A patent/TN2009000180A1/fr unknown
- 2009-05-12 MA MA31864A patent/MA30883B1/fr unknown
- 2009-05-12 IL IL198718A patent/IL198718A/en active IP Right Grant
- 2009-05-13 GT GT200900125A patent/GT200900125A/es unknown
- 2009-05-13 EC EC2009009327A patent/ECSP099327A/es unknown
- 2009-05-14 US US12/465,911 patent/US7956085B2/en active Active
2011
- 2011-02-04 CY CY20111100133T patent/CY1111166T1/el unknown
2017
- 2017-07-12 AR ARP170101938A patent/AR109033A2/es unknown
2018
- 2018-04-11 NO NO20180497A patent/NO344589B1/no unknown

Also Published As

Publication number	Publication date
CA2669230C (en)	2015-01-13
CO6190534A2 (es)	2010-08-19
IL198718A (en)	2012-12-31
NO20091893L (no)	2009-07-09
ECSP099327A (es)	2009-06-30
US7956085B2 (en)	2011-06-07
EP2084172B1 (de)	2010-12-22
NZ576762A (en)	2010-11-26
SV2009003216A (es)	2010-05-26
SI2084172T1 (sl)	2011-03-31
CN101535326B (zh)	2012-10-31
MY148429A (en)	2013-04-30
EP2084172A1 (de)	2009-08-05
TWI414530B (zh)	2013-11-11
ATE492554T1 (de)	2011-01-15
KR20090082396A (ko)	2009-07-30
DK2084172T3 (da)	2011-04-04
AR063786A1 (es)	2009-02-18
NI200900076A (es)	2010-01-29
AU2007321496A1 (en)	2008-05-22
RU2009122470A (ru)	2010-12-20
CA2865332A1 (en)	2008-05-22
DE502007006055D1 (de)	2011-02-03
JP5301453B2 (ja)	2013-09-25
CA2865332C (en)	2016-03-29
GT200900125A (es)	2011-06-23
IL198718A0 (en)	2010-02-17
BRPI0718813A2 (pt)	2013-12-03
BRPI0718813B8 (pt)	2021-05-25
CA2669230A1 (en)	2008-05-22
CL2007003262A1 (es)	2008-05-30
NO344589B1 (no)	2020-02-03
CN101535326A (zh)	2009-09-16
KR101489168B1 (ko)	2015-02-03
JP2010509379A (ja)	2010-03-25
WO2008058628A1 (de)	2008-05-22
HRP20110197T1 (hr)	2011-04-30
BRPI0718813B1 (pt)	2020-12-08
ES2358371T3 (es)	2011-05-10
NO342236B1 (no)	2018-04-23
US20100035961A1 (en)	2010-02-11
CR10733A (es)	2009-05-25
UY30709A1 (es)	2008-07-03
RU2456282C2 (ru)	2012-07-20
HK1137762A1 (en)	2010-08-06
AR109033A2 (es)	2018-10-24
TN2009000180A1 (en)	2010-10-18
AU2007321496B2 (en)	2012-07-26
MX2009003958A (es)	2009-04-27
DE102006053635A1 (de)	2008-05-15
CY1111166T1 (el)	2015-06-11
NO20180497A1 (no)	2009-07-09
PT2084172E (pt)	2011-02-10
DE102006053635B4 (de)	2011-06-30
TW200837072A (en)	2008-09-16
MA30883B1 (fr)	2009-11-02
PE20081493A1 (es)	2008-11-24

Publication	Publication Date	Title
IL198718A0 (en)	2010-02-17	Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
HUS1400056I1 (hu)	2016-08-29	Glükopiranozil-helyettesített benzol-származékok, az említett vegyületeket tartalmazó gyógyszerek, azok alkalmazása, és eljárás elõállításukra
IL188606A0 (en)	2008-04-13	Novel 1,4-benzothiazepine-1,1-dioxide, derivative having improved properties, method for the production thereof, medicaments containing said compound, and use thereof
ZA200900707B (en)	2010-05-26	Substituted spiroketal derivatives and use thereof as therapeutic drug for diabetes
IL176916A0 (en)	2006-12-10	Aryl substituted heterocycles, method for production and use thereof as medicaments
IL181012A0 (en)	2007-07-04	Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments
ATE460401T1 (de)	2010-03-15	1,2,4,5-tetrahydro-3h-benzazepinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
IL193772A0 (en)	2009-08-03	4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same
IL195245A0 (en)	2009-09-22	Substituted prolinamides, production thereof and their use as drugs
IL191988A0 (en)	2008-12-29	Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof
PL2401263T3 (pl)	2016-08-31	Podstawione pochodne azotu, zawierająca pochodne kompozycja farmaceutyczna, i sposób leczenia choroby Parkinsona przy ich użyciu
IL187713A0 (en)	2008-08-07	3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
IL179758A (en)	2010-12-30	Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof and use of the same as medicaments
IL184314A0 (en)	2007-10-31	Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
IL193155A0 (en)	2009-02-11	Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
EP2025667A4 (en)	2012-08-29	9, 10-SECOPREGNANDERIVAT AND MEDICINAL PRODUCTS
IL186862A0 (en)	2008-02-09	Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
ZA200807321B (en)	2009-07-29	Substituted imidazo[2,1-b]thiazole compounds and their use for producing drugs
ATE462408T1 (de)	2010-04-15	Pharmazeutische zusammensetzungen, enthaltend valatograst, und verfahren zu deren herstellung
ATE372992T1 (de)	2007-09-15	Indanyl-piperazinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
IL178887A0 (en)	2007-03-08	Novel beta agonists, method for producing the same and their use as drugs
ATE466863T1 (de)	2010-05-15	Neue aminopyrrolo-ä1,2-aü-indol- und aminopyridazino-ä1,6-aü-indol-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen damit
PL1999112T3 (pl)	2015-10-30	Podstawione 2-amino-4-fenylo-dihydrochinoliny, sposób ich wytwarzania, ich zastosowanie jako leku i lek je zawierający
SI1906926T1 (sl)	2011-02-28	Farmacevtski sestavek, ki obsega 2,3-dihidro-6-nitroimidazo(2,1-b)oksazolne derivate
ZA200805656B (en)	2009-11-25	Prodrug ER²-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds